Keyword: Harvard University
Broad Institute scientists have created an RNA-editing method that makes reversible changes to DNA possible.
Researchers at Massachusetts Eye and Ear have found a group of blood-based biomarkers that could improve diagnosis and treatment for AMD.
Harvard University researchers have identified an enzyme that protects cells from harmful fats, which could inform new obesity treatments.
The past week brought new discoveries in overeating and obesity, the genes that promote cancer and a new way to prevent sunburn.
Researchers have uncovered clues into how a genetic variant raises the risk of migraines, coronary artery disease and other related disorders.
Shares in Editas Medicine rose 30% after the U.S. patent office sided with the Broad Institute in the legal tussle over CRISPR gene editing.
Researchers at the University of Oregon have discovered a protein in the guts of zebrafish that has the power to boost insulin production.
Chemotherapy drugs don’t always work, thanks to resistance in cancer cells. Now, researchers from Harvard University’s Wyss Institute have found a way to analyze how the stiffness of the “extracellular matrix”--the material that surrounds cells--can affect drug efficacy in cancer treatment.
Harvard chemists have designed a new platform for antibiotics development, hoping to fend off the so-called postantibiotic era.
Today, one of the biotechs Greg Verdine co-founded announced a $911 million discovery pact with Pfizer, which includes a $40 million upfront.